Superworth

Scynexis EPS SCYX

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$2.17
Latest quarter, Q2 FY26
$0.63
Fiscal year 2025
−$1.43

Scynexis' earnings per share was −$2.17 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was $0.63.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.43n/a
FY2024−$3.52−134%
FY2023$10.40n/a
FY2022−$11.28n/a
FY2021−$12.72n/a
FY2020−$40.48n/a
FY2019−$78.64n/a
FY2018−$24.00n/a
FY2017−$78.40n/a
FY2016−$136.00n/a
FY2015−$218.40n/a
FY2014−$668.80n/a
FY2013−$11182.40n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$0.63n/a−$2.17
Q1 FY26−$3.36n/a−$3.91
Q4 FY25$1.92n/a−$1.43
Q3 FY25−$1.36n/a−$4.07
Q2 FY25−$1.11n/a−$3.19
Q1 FY25−$0.88−1200%−$4.48
Q4 FY24−$0.72n/a−$3.52
Q3 FY24−$0.48n/a−$6.08
Q2 FY24−$2.40−112%−$5.92
Q1 FY24$0.08n/a$16.16
Q4 FY23−$3.28n/a$10.40
Q3 FY23−$0.32n/a$11.28

Against its peers

Companies in Drug Manufacturers - General nearest Scynexis' size, closest first, today.

CompanyEPS, 12 monthsGrowth
SCYXScynexis−$2.17
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Scynexis

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.